Search
for
Sort by
Research 30 of 66
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Teledermatology in the COVID-19 pandemic: A systematic review
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Dermatologic Reactions to Targeted Therapy
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series
- Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of ‘Dermatology for Cancer Patients’
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
- Short anagen syndrome: Case series and literature review
- Dermatological adverse events with taxane chemotherapy
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- The Hair Shedding Visual Scale: A Quick Tool to Assess Hair Loss in Women
- Seborrheic Dermatitis: Three Novel Trichoscopic Signs and Its Correlation to <i>Malassezia</i> sp. Colonization
- New therapies for alopecia areata
- Use of modern technological devices (photography, mobile phone applications and artificial intelligence) in dermatology
- Hair disorders in patients with cancer
- Characterization of the role of Facebook groups for patients who use scalp cooling therapy: a survey study
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Alopecia With Endocrine Therapies in Patients With Cancer
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Monitoring chemotherapy‐induced alopecia with trichoscopy
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Dermatologic Adverse Events from Cancer Treatments
- Chemotherapy and Cutaneous Drug Reactions
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- Subject Index